Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 10
2004 6
2005 9
2006 20
2007 15
2008 12
2009 17
2010 11
2011 12
2012 16
2013 25
2014 34
2015 28
2016 42
2017 37
2018 26
2019 10
2020 11
2021 21
2022 18
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

329 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Nakachi K, et al. Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4. Lancet. 2023. PMID: 36681415 Clinical Trial.
Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.
Kubo S, Shinkawa H, Asaoka Y, Ioka T, Igaki H, Izumi N, Itoi T, Unno M, Ohtsuka M, Okusaka T, Kadoya M, Kudo M, Kumada T, Kokudo N, Sakamoto M, Sakamoto Y, Sakurai H, Takayama T, Nakashima O, Nagata Y, Hatano E, Harada K, Murakami T, Yamamoto M. Kubo S, et al. Among authors: sakamoto y. Liver Cancer. 2022 Feb 23;11(4):290-314. doi: 10.1159/000522403. eCollection 2022 Jul. Liver Cancer. 2022. PMID: 35978598 Free PMC article.
The Tokyo 2020 terminology of liver anatomy and resections: Updates of the Brisbane 2000 system.
Wakabayashi G, Cherqui D, Geller DA, Abu Hilal M, Berardi G, Ciria R, Abe Y, Aoki T, Asbun HJ, Chan ACY, Chanwat R, Chen KH, Chen Y, Cheung TT, Fuks D, Gotohda N, Han HS, Hasegawa K, Hatano E, Honda G, Itano O, Iwashita Y, Kaneko H, Kato Y, Kim JH, Liu R, López-Ben S, Morimoto M, Monden K, Rotellar F, Sakamoto Y, Sugioka A, Yoshiizumi T, Akahoshi K, Alconchel F, Ariizumi S, Benedetti Cacciaguerra A, Durán M, Garcia Vazquez A, Golse N, Miyasaka Y, Mori Y, Ogiso S, Shirata C, Tomassini F, Urade T, Wakabayashi T, Nishino H, Hibi T, Kokudo N, Ohtsuka M, Ban D, Nagakawa Y, Ohtsuka T, Tanabe M, Nakamura M, Tsuchida A, Yamamoto M. Wakabayashi G, et al. Among authors: sakamoto y. J Hepatobiliary Pancreat Sci. 2022 Jan;29(1):6-15. doi: 10.1002/jhbp.1091. Epub 2021 Dec 20. J Hepatobiliary Pancreat Sci. 2022. PMID: 34866349
Development of conversion therapy for advanced hepatocellular carcinoma.
Matsuki R, Kogure M, Hasui N, Momose H, Suzuki Y, Sakamoto Y. Matsuki R, et al. Among authors: sakamoto y. Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):453-456. doi: 10.21037/hbsn-23-204. Epub 2023 May 10. Hepatobiliary Surg Nutr. 2023. PMID: 37351138 Free PMC article. No abstract available.
Postoperative adjuvant therapy.
Kosuge T, Sakamoto Y, Ueno H. Kosuge T, et al. Among authors: sakamoto y. J Hepatobiliary Pancreat Sci. 2011 Nov;18(6):792-6. doi: 10.1007/s00534-011-0433-2. J Hepatobiliary Pancreat Sci. 2011. PMID: 21874279 Review.
Trends in the treatment of pancreatic cancer in Japan.
Matsuki R, Arai T, Kogure M, Suzuki Y, Sakamoto Y. Matsuki R, et al. Among authors: sakamoto y. Biosci Trends. 2021 Jul 6;15(3):135-137. doi: 10.5582/bst.2021.01103. Epub 2021 Mar 26. Biosci Trends. 2021. PMID: 33776020 Free article.
Expert Consensus Guidelines: How to safely perform minimally invasive anatomic liver resection.
Gotohda N, Cherqui D, Geller DA, Abu Hilal M, Berardi G, Ciria R, Abe Y, Aoki T, Asbun HJ, Chan ACY, Chanwat R, Chen KH, Chen Y, Cheung TT, Fuks D, Han HS, Hasegawa K, Hatano E, Honda G, Itano O, Iwashita Y, Kaneko H, Kato Y, Kim JH, Liu R, López-Ben S, Morimoto M, Monden K, Rotellar F, Sakamoto Y, Sugioka A, Yoshiizumi T, Akahoshi K, Alconchel F, Ariizumi S, Benedetti Cacciaguerra A, Durán M, Garcia Vazquez A, Golse N, Miyasaka Y, Mori Y, Ogiso S, Shirata C, Tomassini F, Urade T, Wakabayashi T, Nishino H, Hibi T, Kokudo N, Ohtsuka M, Ban D, Nagakawa Y, Ohtsuka T, Tanabe M, Nakamura M, Yamamoto M, Tsuchida A, Wakabayashi G. Gotohda N, et al. Among authors: sakamoto y. J Hepatobiliary Pancreat Sci. 2022 Jan;29(1):16-32. doi: 10.1002/jhbp.1079. Epub 2021 Nov 29. J Hepatobiliary Pancreat Sci. 2022. PMID: 34779150
Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression.
Matsuki R, Okano N, Hasui N, Kawaguchi S, Momose H, Kitahama K, Nagahama K, Kogure M, Suzuki Y, Nagashima F, Shibahara J, Mori H, Sakamoto Y. Matsuki R, et al. Among authors: sakamoto y. Liver Cancer. 2022 Oct 25;12(2):180-183. doi: 10.1159/000527250. eCollection 2023 Jun. Liver Cancer. 2022. PMID: 37325496 Free PMC article. No abstract available.
Partial TIPE ALPPS for Perihilar Cancer.
Sakamoto Y, Matsumura M, Yamashita S, Ohkura N, Hasegawa K, Kokudo N. Sakamoto Y, et al. Ann Surg. 2018 Feb;267(2):e18-e20. doi: 10.1097/SLA.0000000000002484. Ann Surg. 2018. PMID: 28857819 No abstract available.
329 results